Incyte weak 2026 revenue forecast heightens Jakafi patent concerns [Yahoo! Finance Canada]
Incyte Corporation (INCY)
Last incyte corporation earnings: 2/13 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
incyte.com/ir/investor-overview.aspx
Company Research
Source: Yahoo! Finance Canada
Shares of the Wilmington, Delaware-based company fell over 4% ?in premarket trading. Incyte expects 2026 revenue between $4.77 billion and $4.94 billion, well below analysts' average estimate of $5.52 billion, according to LSEG data. The weak forecast underscores pressure on Opzelura, the skin disorder treatment Incyte is banking on to ?drive future growth as ?Jakafi faces patent expiration in 2028. The company expects Opzelura to generate $750 million to $790 million in 2026 revenue, below ?the $801.5 million analysts estimate. The cautious forecast comes despite strong fourth-quarter performance, with Opzelura sales jumping 28% to $207.3 million, beating estimates of $195.6 million. BMO analyst Evan Seigerman said ?the "softer guide for Opzelura leaves work to be done in 2026," ?as investors watch whether growth products can fill the gap after Jakafi's patent expiration. Opzelura is used for vitiligo and atopic dermatitis in patients aged 12 and older. The company expec
Show less
Read more
Impact Snapshot
Event Time:
INCY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
INCY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
INCY alerts
High impacting Incyte Corporation news events
Weekly update
A roundup of the hottest topics
INCY
News
- Incyte (NASDAQ:INCY) had its price target lowered by analysts at Royal Bank Of Canada from $95.00 to $92.00. They now have a "sector perform" rating on the stock.MarketBeat
- Incyte (NASDAQ:INCY) was given a new $102.00 price target on by analysts at Morgan Stanley.MarketBeat
- Incyte: Why The Market Is Overreacting To A Guidance 'Miss' [Seeking Alpha]Seeking Alpha
- Incyte (NASDAQ:INCY) had its price target lowered by analysts at Wells Fargo & Company from $107.00 to $101.00. They now have an "equal weight" rating on the stock.MarketBeat
- Incyte (NASDAQ:INCY) was given a new $120.00 price target on by analysts at Stifel Nicolaus.MarketBeat
INCY
Earnings
- 2/10/26 - Beat
INCY
Sec Filings
- 2/10/26 - Form SCHEDULE
- 2/10/26 - Form 10-K
- 2/10/26 - Form 8-K
- INCY's page on the SEC website